Recurrent loss: when IVF alone isn't the answer
PGT-A, immunology, uterine factors, and the emotional reality of pregnancy loss after treatment.
- 01
Most early losses are chromosomal — PGT-A meaningfully reduces that risk.
- 02
Uterine evaluation (saline sonogram, hysteroscopy) is essential after recurrent loss.
- 03
Reproductive immunology is real but easily overprescribed — choose carefully.
- 04
A loss after a euploid transfer is not a failure of your body; it's a signal to look further.
Recurrent pregnancy loss is one of the hardest conversations I have. And one of the most important things I tell patients on day one is: this is not your fault, and we can almost always learn something.
The first thing we look at is whether the losses were chromosomally normal. PGT-A on embryos before transfer dramatically lowers the chance of a chromosomal loss. But if a loss happens after a euploid transfer, that's our cue to look at uterine factors and immunology.
I want to be careful about reproductive immunology. There are real findings — antiphospholipid syndrome, certain thyroid antibodies — and there are findings that don't yet have rigorous data behind them. We treat what's evidence-based and we don't add cost or risk for the rest.
Transcript edited for clarity. The audio is the authoritative source.
Subscribe to the podcast
Liked "Recurrent loss: when IVF alone isn't the answer"? Get the next episode as soon as it drops.
Book a private consultation
Bring your questions from the episode to a one-on-one conversation with Dr. Ghadir. Discuss your goals, options, and a plan that fits you.
